Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription 07.05.2018 1 AJR Am J Roentgenol 1 Am J Surg 1 Ann Oncol 1 Ann Surg Oncol 7 Anticancer Res 3 BMC Cancer 4 Breast Cancer Res 3 Breast Cancer Res Treat 1 Cancer 1 Cancer Epidemiol Biomarkers Prev 3 Clin Breast Cancer 1 Curr Treat Options Oncol 3 Eur J Surg Oncol 1 Eur Radiol 1 Histopathology 3 Int J Cancer 1 J Clin Invest 1 J Clin Oncol 2 J Natl Cancer Inst 1 J Pathol 1 JAMA 1 Lancet Oncol 1 Nat Rev Cancer 4 Oncogene 2 PLoS One 2 Radiology 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. SCHEEL JR, Kim E, Partridge SC, Lehman CD, et al
   MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
   AJR Am J Roentgenol. 2018 Apr 30:1-10. doi: 10.2214/AJR.17.18323.
   PubMed     Text format     Abstract available
   
   

   
   Am J Surg

2. PARK VY, Kim EK, Moon HJ, Yoon JH, et al
   Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery.
   Am J Surg. 2018 Apr 21. pii: S0002-9610(17)31185.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

3. HORTOBAGYI GN, Stemmer SM, Burris HA, Yap YS, et al
   Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
   Ann Oncol. 2018 Apr 27. pii: 4989216. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

4. ELDER K, Nickson C, Pattanasri M, Cooke S, et al
   Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.
   Ann Surg Oncol. 2018 May 1. pii: 10.1245/s10434-018-6469.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

5. TUNGSUKRUTHAI S, Petpiroon N, Chanvorachote P
   Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds.
   Anticancer Res. 2018;38:2607-2618.
   PubMed     Text format     Abstract available
   
   
6. REINHARDT A, Liu H, Ma Y, Zhou Y, et al
   Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
   Anticancer Res. 2018;38:2669-2682.
   PubMed     Text format     Abstract available
   
   
7. MINAFRA L, Bravata V, Cammarata FP, Russo G, et al
   Radiation Gene-expression Signatures in Primary Breast Cancer Cells.
   Anticancer Res. 2018;38:2707-2715.
   PubMed     Text format     Abstract available
   
   
8. KORONOWICZ AA, Drozdowska M, Banks P, Piasna-Slupecka E, et al
   Fatty Acids of CLA-enriched Egg Yolks Can Induce Mitochondrial Pathway of Apoptosis in MCF-7 Breast Cancer Cells.
   Anticancer Res. 2018;38:2861-2870.
   PubMed     Text format     Abstract available
   
   
9. GOTO W, Kashiwagi S, Asano Y, Takada K, et al
   Eribulin Promotes Antitumor Immune Responses in Patients with Locally Advanced or Metastatic Breast Cancer.
   Anticancer Res. 2018;38:2929-2938.
   PubMed     Text format     Abstract available
   
   
10. LUMACHI F, Basso SMM, Camozzi V, Spaziante R, et al
    Bone Mineral Density as a Potential Predictive Factor for Luminal-type Breast Cancer in Postmenopausal Women.
    Anticancer Res. 2018;38:3049-3054.
    PubMed     Text format     Abstract available
    
    
11. CHANG J, Charalel R, Noda C, Ramaswamy R, et al
    Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization.
    Anticancer Res. 2018;38:3063-3068.
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

12. LI W, Xu L, Che X, Li H, et al
    C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.
    BMC Cancer. 2018;18:507.
    PubMed     Text format     Abstract available
    
    
13. DI GIROLAMO C, Walters S, Benitez Majano S, Rachet B, et al
    Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013.
    BMC Cancer. 2018;18:492.
    PubMed     Text format     Abstract available
    
    
14. FERNANDO A, Jayarajah U, Prabashani S, Fernando EA, et al
    Incidence trends and patterns of breast cancer in Sri Lanka: an analysis of the national cancer database.
    BMC Cancer. 2018;18:482.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res

15. KISH JK, Ward MA, Garofalo D, Ahmed HV, et al
    Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval.
    Breast Cancer Res. 2018;20:37.
    PubMed     Text format     Abstract available
    
    
16. WANDERS JOP, van Gils CH, Karssemeijer N, Holland K, et al
    The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Breast Cancer Res. 2018;20:36.
    PubMed     Text format     Abstract available
    
    
17. CHEN BT, Sethi SK, Jin T, Patel SK, et al
    Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
    Breast Cancer Res. 2018;20:38.
    PubMed     Text format     Abstract available
    
    
18. PADUA MB, Bhat-Nakshatri P, Anjanappa M, Prasad MS, et al
    Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
    Breast Cancer Res. 2018;20:35.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

19. KIM S, Ko Y, Lee HJ, Lim JE, et al
    Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
    Breast Cancer Res Treat. 2018 Apr 30. pii: 10.1007/s10549-018-4782.
    PubMed     Text format     Abstract available
    
    
20. ERIN N, Ogan N, Yerlikaya A
    Correction to: Secretomes reveal several novel proteins as well as TGF-beta1 as the top upstream regulator of metastatic process in breast cancer.
    Breast Cancer Res Treat. 2018 May 2. pii: 10.1007/s10549-018-4781.
    PubMed     Text format     Abstract available
    
    
21. KOMMALAPATI A, Tella SH, Goyal G, Ganti AK, et al
    A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Breast Cancer Res Treat. 2018 May 2. pii: 10.1007/s10549-018-4802.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

22. VALACHIS A, Mamounas EP, Mittendorf EA, Hayashi N, et al
    Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.
    Cancer. 2018 May 3. doi: 10.1002/cncr.31518.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

23. FARVID MS, Eliassen AH, Cho E, Chen WY, et al
    Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2018;27:575-584.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

24. NG T, Phey XY, Yeo HL, Shwe M, et al
    Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Clin Breast Cancer. 2018 Apr 6. pii: S1526-8209(17)30767.
    PubMed     Text format     Abstract available
    
    
25. UM E, Kang JW, Lee S, Kim HJ, et al
    Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30614.
    PubMed     Text format     Abstract available
    
    
26. CORTES J, Perez-Garcia J, Whiting S, Wan Y, et al
    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
    Clin Breast Cancer. 2018 Mar 30. pii: S1526-8209(17)30778.
    PubMed     Text format     Abstract available
    
    

    
    Curr Treat Options Oncol

27. VAN HELLEMOND IEG, Geurts SME, Tjan-Heijnen VCG
    Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer.
    Curr Treat Options Oncol. 2018;19:26.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

28. LIM GH, Upadhyaya VS, Acosta HA, Lim JMA, et al
    Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
    Eur J Surg Oncol. 2018 Apr 12. pii: S0748-7983(18)31008.
    PubMed     Text format     Abstract available
    
    
29. CSERNI G, Charafe-Jauffret E, van Diest PJ
    Inflammatory breast cancer: The pathologists' perspective.
    Eur J Surg Oncol. 2018 Apr 18. pii: S0748-7983(18)30998.
    PubMed     Text format     Abstract available
    
    
30. WICKBERG A, Liljegren G, Killander F, Lindman H, et al
    Omitting radiotherapy in women >/= 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Eur J Surg Oncol. 2018 Apr 13. pii: S0748-7983(18)31007.
    PubMed     Text format     Abstract available
    
    

    
    Eur Radiol

31. KIM JY, Kim JJ, Kim S, Choo KS, et al
    Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5429.
    PubMed     Text format     Abstract available
    
    

    
    Histopathology

32. JOSEPH C, Papadaki A, Althobiti M, Alsaleem M, et al
    Breast cancer intra-tumour heterogeneity: Current status and clinical implications.
    Histopathology. 2018 May 2. doi: 10.1111/his.13642.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

33. LI J, Wang W, Xia P, Wan L, et al
    Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in breast cancer patients.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31573.
    PubMed     Text format     Abstract available
    
    
34. CAIRAT M, Fournier A, Murphy N, Biessy C, et al
    Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31570.
    PubMed     Text format     Abstract available
    
    
35. BAGLIA ML, Cook LS, Tang MT, Wiggins C, et al
    Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer.
    Int J Cancer. 2018 Apr 30. doi: 10.1002/ijc.31575.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Invest

36. YU J, Qin B, Moyer AM, Nowsheen S, et al
    DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
    J Clin Invest. 2018 Apr 30. pii: 97924. doi: 10.1172/JCI97924.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

37. LAMBERTINI M, Moore HCF, Leonard RCF, Loibl S, et al
    Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
    J Clin Oncol. 2018 May 2:JCO2018780858. doi: 10.1200/JCO.2018.78.0858.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

38. JAYASEKERA J, Li Y, Schechter CB, Jagsi R, et al
    Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
    J Natl Cancer Inst. 2018 Apr 28. pii: 4990602. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
39. DESMEDT C, Demicheli R, Fornili M, Bachir I, et al
    Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.
    J Natl Cancer Inst. 2018 Apr 30. pii: 4975381. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Pathol

40. BARTELS S, van Luttikhuizen JL, Christgen M, Magel L, et al
    CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    J Pathol. 2018 Apr 30. doi: 10.1002/path.5091.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

41. KEATING NL, Pace LE
    Breast Cancer Screening in 2018: Time for Shared Decision Making.
    JAMA. 2018;319:1814-1815.
    PubMed     Text format    
    
    

    
    Lancet Oncol

42. PERNAS S, Martin M, Kaufman PA, Gil-Martin M, et al
    Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
    Lancet Oncol. 2018 Apr 26. pii: S1470-2045(18)30147.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Cancer

43. LIM B, Woodward WA, Wang X, Reuben JM, et al
    Inflammatory breast cancer biology: the tumour microenvironment is key.
    Nat Rev Cancer. 2018 Apr 27. pii: 10.1038/s41568-018-0010.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

44. CHEN A, Sceneay J, Godde N, Kinwel T, et al
    Intermittent hypoxia induces a metastatic phenotype in breast cancer.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
    PubMed     Text format     Abstract available
    
    
45. PAVAN S, Meyer-Schaller N, Diepenbruck M, Kalathur RKR, et al
    A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0270.
    PubMed     Text format     Abstract available
    
    
46. CHANG JW, Kuo WH, Lin CM, Chen WL, et al
    Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0253.
    PubMed     Text format     Abstract available
    
    
47. AHIRWAR DK, Nasser MW, Ouseph MM, Elbaz M, et al
    Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0263.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

48. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    PubMed     Text format     Abstract available
    
    
49. VERONESE P, Hachul DT, Scanavacca MI, Hajjar LA, et al
    Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
    PLoS One. 2018;13:e0196763.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

50. GILLIES RJ, Balagurunathan Y
    Perfusion MR Imaging of Breast Cancer: Insights Using "Habitat Imaging".
    Radiology. 2018 Apr 27:180271. doi: 10.1148/radiol.2018180271.
    PubMed     Text format    
    
    
51. WU J, Cao G, Sun X, Lee J, et al
    Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Radiology. 2018 Apr 27:172462. doi: 10.1148/radiol.2018172462.
    PubMed     Text format     Abstract available
    
    

    
    Radiother Oncol

52. GERNAAT SAM, van Velzen SGM, Koh V, Emaus MJ, et al
    Automatic quantification of calcifications in the coronary arteries and thoracic aorta on radiotherapy planning CT scans of Western and Asian breast cancer patients.
    Radiother Oncol. 2018 Apr 24. pii: S0167-8140(18)30199.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: